Is it worth buying CVS Health stock at a price of $67.77? If this question is on your mind, make sure to check out the fundamentals of this Pharmaceutical Retail Large-Cap company:
-
CVS Health has logged a 10.4% 52 week change, compared to 9.2% for the S&P 500
-
CVS has an average analyst rating of buy and is -14.74% away from its mean target price of $79.49 per share
-
Its trailing earnings per share (EPS) is $4.19, which brings its trailing Price to Earnings (P/E) ratio to 16.2. The Consumer Staples sector's average P/E ratio is 25.91
-
The company's forward earnings per share (EPS) is $6.48 and its forward P/E ratio is 10.5
-
The company has a Price to Book (P/B) ratio of 1.11 in contrast to the Consumer Staples sector's average P/B ratio is 3.03
-
The current ratio is currently 0.8, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
CVS has reported YOY quarterly earnings growth of 60.2% and gross profit margins of 0.1%
-
The company's free cash flow for the last fiscal year was $6.33 Billion and the average free cash flow growth rate is -11.9%
-
CVS Health's revenues have an average growth rate of 7.2% with operating expenses growing at 20.4%. The company's current operating margins stand at 2.3%